# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1174102 | Binding | Inhibition of CDC2L5 at 10 uM | 2 | ALA1177794 | single protein format | Scientific Literature | ||
2. | ALA1837581 | Binding | Inhibition of human CHED in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control | Homo sapiens | 5 | ALA1833925 | cell-based format | Scientific Literature | |
3. | ALA1908458 | Binding | Binding constant for CDC2L5 kinase domain | 72 | ALA1908390 | single protein format | Scientific Literature | ||
4. | ALA4389146 | Binding | Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4387741 | assay format | Scientific Literature | |
5. | ALA4389623 | Binding | Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4387741 | assay format | Scientific Literature | |
6. | ALA4382427 | Binding | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4382192 | assay format | Scientific Literature | |
7. | ALA1944422 | Binding | Inhibition of human CHED in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM | Homo sapiens | 4 | ALA1938230 | cell-based format | Scientific Literature | |
8. | ALA4365641 | Binding | Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4364269 | assay format | Scientific Literature | |
9. | ALA2209339 | Binding | Inhibition of CDC2L5 assessed as residual activity at 10 uM relative to control | 1 | ALA2203081 | single protein format | Scientific Literature | ||
10. | ALA3991653 | Binding | Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry. | Homo sapiens | 242 | ALA3991601 | subcellular format | Kuster lab chemical proteomics drug profiling | |
11. | ALA4025049 | Binding | Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4024706 | assay format | Scientific Literature | |
12. | ALA4043860 | Binding | Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control | Homo sapiens | 1 | ALA4043093 | cell-based format | Scientific Literature | |
13. | ALA4054987 | Binding | Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control | Homo sapiens | 2 | ALA4052645 | assay format | Scientific Literature | |
14. | ALA4118325 | Binding | Inhibition of CHED in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKCSNILLNNR probe by mass-spectrometric analysis relative to control | Homo sapiens | 3 | ALA4118021 | cell-based format | Scientific Literature | |
15. | ALA4156939 | Binding | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4152344 | assay format | Scientific Literature | |
16. | ALA4185718 | Binding | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control | Homo sapiens | 2 | ALA4184148 | cell-based format | Scientific Literature | |
17. | ALA4230618 | Binding | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4229344 | assay format | Scientific Literature | |
18. | ALA4264207 | Binding | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4261600 | assay format | Scientific Literature | |
19. | ALA4307723 | Binding | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4304811 | assay format | Scientific Literature | |
20. | ALA4333314 | Binding | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4330132 | assay format | Scientific Literature |